1. Coming to America Establishing a Business Presence in the United States of America Presented by: Jordan Warshafsky COO, BioPortUSA

2. US R x Sales US $ 275 billion US $ 275 billion 43% share 43% share 8.3 % growth 8.3 % growth …single largest health care market in the world!

3.  Center for Medicare Management  Center for Medicaid and State Operations  Office of the Administrator  Office of Clinical Standards and Quality  Office of E-Health Standards and Services  Office of Research, Development and Information  Office of Strategic Operations and Regulatory Affairs  Center for Food Safety & Applied Nutrition  Center for Drug Evaluation & Research  Center for Devices & Radiological Health  Center for Biologics Evaluation & Research  Center for Veterinary Medicine  Office of Regulatory Affairs  National Center for Toxicological Research B I O T E C H N O L O G Y – M E D I C A L D E V I C E S Department of Treasury Internal Revenue Service Department of Justice Drug Enforcement Administration Department of Labor Occupational Safety and Health Administration Department of Transportation National Institutes of Health Centers for Medicare & Medicaid Services Food and Drug Administration Department of Health and Human Services Office of Inspector General Environmental Protection Agency Securities and Exchange Commission Customs and Border Protection Department of Homeland Security Department of Commerce Patent and Trademark Office Department of Agriculture Sample of US federal agencies that regulate medical companies USA Regulatory Environment

4. Laws Enforced by the FDA Infant Formula Act of 1980 (summary) Orphan Drug Act Drug Price Competition and Patent Term Restoration Act of 1984 (summary) Drug Price Competition and Patent Term Restoration Act of 1984 (summary) Prescription Drug Marketing Act of 1987 Generic Animal Drug and Patent Term Restoration Act of 1988 (summary) Generic Animal Drug and Patent Term Restoration Act of 1988 (summary) Nutrition Labeling and Education Act of 1990 Safe Medical Devices Act of 1990 (summary) Safe Medical Devices Act of 1990 (summary) Medical Device Amendments of 1992 (summary) Medical Device Amendments of 1992 (summary) Prescription Drug Amendments of 1992 Prescription Drug User Fee Act (PDUFA) of 1992 Prescription Drug User Fee Act (PDUFA) of 1992 Animal Medicinal Drug Use Clarification Act (AMDUCA) of 1994 Animal Medicinal Drug Use Clarification Act (AMDUCA) of 1994 Dietary Supplement Health and Education Act of 1994 Dietary Supplement Health and Education Act of 1994 Food Quality Protection Act of 1996 Animal Drug Availability Act of 1996 Food and Drug Administration Modernization Act (FDAMA) of 1997 Food and Drug Administration Modernization Act (FDAMA) of 1997 Best Pharmaceuticals for Children Act Medical Device User Fee and Modernization Act (MDUFMA) of 2002 Medical Device User Fee and Modernization Act (MDUFMA) of 2002 Animal Drug User Fee Act of 2003 Pediatric Research Equity Act of 2003 Minor Use and Minor Species Animal Health Act of 2004 Minor Use and Minor Species Animal Health Act of 2004 Food Allergen Labeling and Consumer Protection Act of 2004 Food Allergen Labeling and Consumer Protection Act of 2004

5. Medicare Fundamentals In 1965, the federal government established Medicare The Center for Medicare and Medicaid Services (CMS) administers the program men and women age 65 and older people of any age with permanent kidney failure persons under age 65 with disabilities. Medicare comprises three parts Part A (Hospital Insurance) Part B (Medical Insurance) Part D (Prescription Drug subsidy) – Jan. 2006

6. Today’s US Health Care Environment is Complex with Multiple Barriers to Entry Medical Device/ Biotech Company Insurance Companies Employers Employer Coalitions PPO Fiscal Intermediaries Distribution Medicare Pharmacy Benefit Mgmt. Co Physician Office Mgmt. Co. Group Practice Guidelines Nurse Pharmacist IPA MD Clinics FSDC chains Formularies, Protocols Medicaid CMS State Govts. HMO State Assistance Programs Provider Corporations Integrated Healthcare Systems Academic Med. Centers Provider Societies ASCO, NKF, NCCN Hospitals Hospital Group Purchasing Circle of Involved Patients Internet DOD, DVA Prisons Federal Govts. FDA Pharma/BIO Trade Groups Generics Manufacturing

7. Key Consideration # 1 Do you need a US market presence to achieve business success?

8. Questions you need to ask… What is the strategic vision for the business ? What is the strategic vision for the business ? Does this require global market expansion ? Does this require global market expansion ? Will this maximize valuations of IP, product assets, and equity of stakeholders? Will this maximize valuations of IP, product assets, and equity of stakeholders? Will you have support of Board and Management Team ? Will you have support of Board and Management Team ? Will you have adequate financial resources ? Will you have adequate financial resources ?

9. Key Consideration # 2 What are the critical What are the critical legal and financial issues ?

10. Differences between US and Domestic market Business entity structure Business entity structure Intellectual Property protection Intellectual Property protection Immigration laws and restrictions (since 9/11) Immigration laws and restrictions (since 9/11) Employment law issues Employment law issues Executive compensation programs Executive compensation programs Antitrust and trade regulations Antitrust and trade regulations Tax considerations Tax considerations Transfer pricing Transfer pricing Sarbanes-Oxley Sarbanes-Oxley

11. Key Consideration # 3 Can you successfully launch your products in the US market?

12. The US Market is rapidly growing…but changing The US Market is rapidly growing…but changing Regulations at the national and state level are more complex Regulations at the national and state level are more complex New rules for promotion and medical education New rules for promotion and medical education Traditional approaches usually mean doing it yourself …… or finding a partner/investor Traditional approaches usually mean doing it yourself …… or finding a partner/investor

13. Does the market need the product? Does the market need the product? Will it sell? Will it sell? Will it be reimbursed? Will it be reimbursed? What is the experience of the What is the experience of the management team? Can we win? Can we win? Questions Often asked by Potential Partners/Investors

14. Key Consideration # 4 What are the issues when deciding on geographical location for the business unit? What are the issues when deciding on geographical location for the business unit?

15. Accessibility to skilled talent Accessibility to skilled talent Cost of living / compensation Cost of living / compensation Proximity to academic centers of excellence Proximity to academic centers of excellence Location of strategic partners Location of strategic partners State & Local tax incentives State & Local tax incentives Biotech specific innovation zones Biotech specific innovation zones R&D tax credit qualifications R&D tax credit qualifications Employee training grants Employee training grants

16. Key Consideration # 5 How will you know that your business is ready for expansion to the US market? How will you know that your business is really ready for expansion to the US market?

17. Key Operating Principles your firm’s “readiness” to enter the US market. (3 rd party review) Assess your firm’s “readiness” to enter the US market. (3 rd party review) Develop a comprehensive US market before committing resources Develop a comprehensive US market commercialization plan before committing resources Hire/contract skilled commercial personnel with Hire/contract skilled commercial personnel with US market experience

18. Business Goals should be Stay for as long as possible Stay “virtual” for as long as possible Manage expenditures () Manage expenditures ($ and time) time to market Accelerate time to market

19. So… if you want to maximize the value of the company and it’s assets …you need to be in the US Market !